ClinicalTrials.gg
CompletedNCT05878470Updated May 26, 2023

Reducing Self-stigma Using Brief Video Intervention

An interventional study of video in Stigma, Social and Mental Health Disorder, sponsored by New York State Psychiatric Institute. Completed at 1 site in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-26.

Sponsored by New York State Psychiatric Institute · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jan 2023, registered May 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
1,214
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

Stigma is a profound obstacle to care. Self-stigma decreases sense of self-competency, as well as healthcare seeking and treatment adherence and creates barriers to pursuing employment, independent living, and fulfilling social life. For example, people with mental disorders avoid, delay, or drop out of treatment due to a fear of labeling and discrimination or experience treatments as ineffective or disrespectful. Therefore, reducing self stigma can reduce self-blame, improve self-confidence and provide support for people living with mental illness.

In a prior study, the investigators developed a short video intervention to reduce self-stigma among people with schizophrenia. The investigators would like to test the efficacy of this video using Prolific (a crowdsourcing platform). Specifically, the investigators are interested in recruiting 1,200 Prolific participants, ages 18-35, who mentioned in their profile while enrolling to Prolific that they have a mental health condition, and randomized them into watching the newly developed video to reduce self-stigma or participate in the non-intervention control arm. Participants will be invited to participate in a follow-up survey 30 days after completing the first survey.

Read the detailed description

The primary objective of this study is to test the video efficacy in reducing self stigma among 1,200 Prolific users who mentioned in their profile while enrolling to Prolific that they have a mental health condition (600 in an intervention group, and 600 in a non-intervention control group). The study participants will be invited to participate in a 30-day follow up questionnaire. The investigators hypothesize finding a reduced level of self-stigma among those who watch the intervention video.

02

Conditions studied

  • Stigma, Social
  • Mental Health Disorder
03

In context

Social Stigma

111 studies on the registry are indexed under Social Stigma; 50 are open to participants now.

This study's enrollment of 1,214 is above the median of 128 across 93 interventional studies indexed under Social Stigma.

Browse Social Stigma studies →

Lead sponsor

New York State Psychiatric Institute is the lead sponsor of 433 studies on the registry; 25 are open to participants now.

Of its 50 completed or terminated interventional studies of FDA-regulated products, 45 (90%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • English-speaking
  • 18-35-year-old
  • US residents
  • Those who answered yes to "Do you have or have you had a diagnosed, ongoing mental health/illness/condition?"

Exclusion criteria

Exclusion Criteria:

  • Non English-speaking
  • Non US residents
  • Age younger than 18 or older than 35
  • People who replied no to the question on ongoing mental health
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
1,214 participants (actual)

Study arms

  • Experimental
    Brief video intervention

    Brief (119 seconds) social contact-based video

    Behavioral: video

  • No intervention
    Non-intervention control

    Non-intervention control

Interventions

  • Behavioralvideo

    A brief (119 seconds) social contact-based video. The video presented a young Black man in his early twenties, a professional actor, sharing his scripted personal story of struggles with psychotic illness and raising themes of recovery and hope.

06

What researchers measure

Primary outcomes

  1. Self-stigma

    The investigators assessed self-stigma using 23 items across six domains: Stereotype Endorsement, Alienation, Stigma Resistance, Perceived Devaluation Discrimination, Secrecy, and Recovery Assessment Scale.

    Time frame: Baseline

  2. Self-stigma

    The investigators assessed self-stigma using 23 items across six domains: Stereotype Endorsement, Alienation, Stigma Resistance, Perceived Devaluation Discrimination, Secrecy, and Recovery Assessment Scale.

    Time frame: Post (immediately after the intervention and for the control immediately after doing the baseline survey)

  3. Self-stigma

    The investigators assessed self-stigma using 23 items across six domains: Stereotype Endorsement, Alienation, Stigma Resistance, Perceived Devaluation Discrimination, Secrecy, and Recovery Assessment Scale.

    Time frame: 30 day follow up

07

Study locations

1 site
  • New York State Psychiatric Institute
    New York, New York 10032, United States
08

References and documents

Publications

  • Amsalem D, Jankowski SE, Yanos P, Yang LH, Markowitz JC, Rogers RT, Stroup TS, Dixon LB, Pope LG. Randomized Controlled Trial of a Brief Video Intervention to Reduce Self-Stigma of Mental Illness. J Clin Psychiatry. 2024 Mar 6;85(1):23m15034. doi: 10.4088/JCP.23m15034. PubMed 38451170 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 26, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05878470
Responsible party
Doron Amsalem (Assistant Professor of Clinical Psychiatry, New York State Psychiatric Institute) — Principal investigator
First posted
May 26, 2023
Start date
Jan 25, 2023
Primary completion
Mar 7, 2023
Completion
Mar 7, 2023
Last update
May 26, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion